NCT07690722

Brief Summary

This study aims to investigate the effects of adding whirlpool therapy to standard rehabilitation in children with cerebral palsy who recently received botulinum toxin-A injections. Participants will be divided into two groups: one group will receive standard physiotherapy, while the other group will receive physiotherapy combined with whirlpool therapy. The effects of these interventions on spasticity, gait function, and motivation will be evaluated over a 12-week follow-up period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
Last Updated

July 8, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

June 13, 2026

Last Update Submit

July 6, 2026

Conditions

Keywords

Cerebral PalsyHemiplegic Cerebral PalsyBotulinum Toxin ASpasticityWhirlpool TherapyHydrotherapyGait AnalysisRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Gross Motor Function Measure-88 (GMFM-88) - Dimension E (Walking, Running and Jumping)

    The primary outcome measure was the Gross Motor Function Measure-88 (GMFM-88) Dimension E, which evaluates walking, running, and jumping abilities in children with hemiplegic cerebral palsy. Each item is scored on a 4-point scale (0-3), and raw scores are converted to percentage values (0-100). Dimension E consists of 24 items, with a maximum raw score of 72 points.

    Baseline (Week 0), Week 4 (post-treatment), Week 12 (follow-up)

Secondary Outcomes (6)

  • Modified Ashworth Scale (MAS)

    Week 0, Week 4, Week 12

  • Pediatric Motivation Scale

    Week 4, Week 12

  • DIERS 4D Motion Analysis System

    Baseline (Week 0), Week 4, Week 12

  • 10-Meter Walk Test (10MWT)

    Baseline (Week 0), Week 4, Week 12

  • Gross Motor Function Measure-88 (GMFM-88) - Dimension D (Standing)

    Baseline (Week 0), Week 4, Week 12

  • +1 more secondary outcomes

Study Arms (2)

Botulinum Toxin + Conventional Physiotherapy + Whirlpool Therapy

EXPERIMENTAL

Patients receiving 4 weeks of conventional physical therapy combined with whirlpool therapy (20 minutes per session, 3 times per week).

Behavioral: Conventional RehabilitationOther: Whirlpool Therapy

Botulinum Toxin + Conventional Physiotherapy

ACTIVE COMPARATOR

Patients receiving 4 weeks of conventional physical therapy alone.

Behavioral: Conventional Rehabilitation

Interventions

Standard rehabilitation program including range of motion exercises, stretching, strengthening, balance, coordination, endurance, and gait training, 5 days per week for 4 weeks under physiotherapist supervision.

Botulinum Toxin + Conventional PhysiotherapyBotulinum Toxin + Conventional Physiotherapy + Whirlpool Therapy

Whirlpool therapy administered 3 times per week for 4 weeks, 20 minutes per session (total 12 sessions), in addition to conventional rehabilitation.

Botulinum Toxin + Conventional Physiotherapy + Whirlpool Therapy

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of hemiplegic cerebral palsy
  • Age between 3 and 10 years
  • Gross Motor Function Classification System (GMFCS) levels I-II
  • Sufficient cognitive level to follow instructions
  • Ability to walk at least 10 meters with an orthosis and/or walking aid
  • Receipt of botulinum toxin injection to the lower extremity within the past week
  • Ability to walk independently for 1 minute without orthosis or assistive device

You may not qualify if:

  • Uncontrolled epilepsy
  • Urinary incontinence
  • Presence of lower extremity contractures
  • History of previous orthopedic surgery
  • Presence of hip subluxation
  • Ataxic or dyskinetic cerebral palsy
  • History of any botulinum toxin injection within the 6 months prior to the current 1-week post-injection period
  • Inability to cooperate during clinical assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Ankara, 06010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral PalsyMuscle Spasticity

Interventions

Hydrotherapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • DAMLA CANKURTARAN, MD

    Ankara Etlik City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors were blinded to group allocation. Participants and physiotherapists were not blinded due to the nature of the intervention. Group assignments were concealed from evaluators during all assessments and data analyses were performed using coded group labels.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a two-arm, parallel-group randomized controlled trial. Participants with hemiplegic cerebral palsy who received recent botulinum toxin-A injections were allocated in a 1:1 ratio to either a conventional physiotherapy group or a conventional physiotherapy plus whirlpool therapy group. The study evaluates the additional effect of whirlpool therapy on rehabilitation outcomes.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

June 13, 2026

First Posted

July 8, 2026

Study Start

February 1, 2025

Primary Completion

May 1, 2026

Study Completion

May 31, 2026

Last Updated

July 8, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations